This study is currently not recruiting participants.

Pharmacotherapy of Pervasive Developmental Disorders & Effects of Aripiprazole on Brain Circuitry in Children and Adolescents with Autism

  • STATUS
    Not Recruiting
Updated on 19 February 2024

Summary

The purpose of this study is to understand the effectiveness of the investigational drug treatment, aripiprazole, for interfering symptoms (aggression, self-injurious behavior, hyperactivity, repetitive behavior) in children and adolescents ages 5 to 17 y

Description

The purpose of this study is to understand the effectiveness of the investigational drug treatment, aripiprazole, for interfering symptoms (aggression, self-injurious behavior, hyperactivity, repetitive behavior) in children and adolescents ages 5 to 17 y

Details
Condition Pervasive Developmental Disorders
Age 5years - 17years
Clinical Study IdentifierTX1629
Last Modified on19 February 2024

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.